EC Number | Cloned (Comment) | Organism |
---|---|---|
2.7.1.149 | - |
Homo sapiens |
EC Number | Crystallization (Comment) | Organism |
---|---|---|
2.7.1.149 | isoform PI5P4Kalpha in complex with inhibitor CVM-05-002, sitting drop vapor diffusion method, using 2 M NH4 (pH 6.5) | Homo sapiens |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
2.7.1.149 | (E)-N-(4-(5-((2,5-dioxopyrrolidin-3-ylidene)methyl)pyridin-3-yl)phenyl)methanesulfonamide | - |
Homo sapiens | |
2.7.1.149 | (Z)-1-(4-(5-((2-imino-4-oxothiazolidin-5-ylidene)methyl)pyridin-3-yl)phenyl)-3-methylurea | - |
Homo sapiens | |
2.7.1.149 | (Z)-2-imino-5-((5-(4-(methylsulfonyl)phenyl)pyridin-3-yl)methylene)thiazolidin-4-one | - |
Homo sapiens | |
2.7.1.149 | (Z)-2-imino-5-((5-(4-(trifluoromethoxy)phenyl)pyridin-3-yl)methylene)thiazolidin-4-one | - |
Homo sapiens | |
2.7.1.149 | (Z)-2-imino-5-((5-(4-(trifluoromethyl)phenyl)pyridin-3-yl)methylene)thiazolidin-4-one | - |
Homo sapiens | |
2.7.1.149 | (Z)-2-imino-5-((5-(4-methoxynaphthalen-1-yl)pyridin-3-yl)methylene)thiazolidin-4-one | - |
Homo sapiens | |
2.7.1.149 | (Z)-4-(5-((2-imino-4-oxothiazolidin-5-ylidene)methyl)pyridin-3-yl)-N-methylbenzenesulfonamide | - |
Homo sapiens | |
2.7.1.149 | (Z)-5-((5-(4-(dimethylamino)phenyl)pyridin-3-yl)methylene)-2-iminothiazolidin-4-one | - |
Homo sapiens | |
2.7.1.149 | (Z)-5-((5-(4-fluorophenyl)pyridin-3-yl)methylene)-2-iminothiazolidin-4-one | - |
Homo sapiens | |
2.7.1.149 | (Z)-N-(3-(5-((2-imino-4-oxothiazolidin-5-ylidene)methyl)pyridin-3-yl)phenyl)acetamide | - |
Homo sapiens | |
2.7.1.149 | (Z)-N-(4-(2-amino-5-((2-imino-4-oxothiazolidin-5-ylidene)-methyl)pyridin-3-yl)phenyl)methanesulfonamide | - |
Homo sapiens | |
2.7.1.149 | (Z)-N-(4-(5-((2,4-dioxo-oxazolidin-5-ylidene)methyl)pyridin-3-yl)phenyl)methanesulfonamide | - |
Homo sapiens | |
2.7.1.149 | (Z)-N-(4-(5-((2,4-dioxothiazolidin-5-ylidene)methyl)pyridin-3-yl)phenyl)methanesulfonamide | - |
Homo sapiens | |
2.7.1.149 | (Z)-N-(4-(5-((2-imino-4-oxothiazolidin-5-ylidene)methyl)pyridin-3-yl)phenyl)acetamide | - |
Homo sapiens | |
2.7.1.149 | (Z)-N-(4-(5-((2-imino-4-oxothiazolidin-5-ylidene)methyl)pyridin-3-yl)phenyl)methanesulfonamide | i.e. CVM-05-002, potent and selective inhibitor for isoform PI5P4Kalpha | Homo sapiens | |
2.7.1.149 | (Z)-N-(4-(6-amino-5-((2-imino-4-oxothiazolidin-5-ylidene)methyl)pyridin-3-yl)phenyl)methanesulfonamide | - |
Homo sapiens | |
2.7.1.149 | N-(3-((5-(4-(methylsulfonamido)phenyl)pyridin-3-yl)amino)phenyl)acetamide | - |
Homo sapiens | |
2.7.1.149 | N-(3-((5-(4-(Mmthylsulfonamido)phenyl)pyridin-3-yl)oxy)phenyl)acetamide | - |
Homo sapiens | |
2.7.1.149 | N-(3-(5-(4-(methylsulfonamido)phenyl)pyridin-3-yl)phenyl)acetamide | - |
Homo sapiens | |
2.7.1.149 | N-(4-(5-(1H-indol-4-yl)pyridin-3-yl)phenyl)methanesulfonamide | - |
Homo sapiens | |
2.7.1.149 | N-(4-(5-(2-oxoindolin-4yl)pyridin-3-yl)phenyl)methanesulfonamide | - |
Homo sapiens | |
2.7.1.149 | N-(4-(5-(4-(3-methylureido)phenyl)pyridin-3-yl)phenyl)methanesulfonamide | - |
Homo sapiens | |
2.7.1.149 | N-(5-(5-(1H-indol-4-yl)pyridin-3-yl)phenyl)methanesulfonamide | - |
Homo sapiens | |
2.7.1.149 | N-(6-(5-(1H-indol-4-yl)pyridin-3-yl)phenyl)methanesulfonamide | - |
Homo sapiens |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.7.1.149 | ATP + 1-phosphatidyl-1D-myo-inositol 5-phosphate | Homo sapiens | - |
ADP + 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.7.1.149 | Homo sapiens | - |
- |
- |
EC Number | Purification (Comment) | Organism |
---|---|---|
2.7.1.149 | - |
Homo sapiens |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
2.7.1.149 | HEK-293T cell | - |
Homo sapiens | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.7.1.149 | ATP + 1-phosphatidyl-1D-myo-inositol 5-phosphate | - |
Homo sapiens | ADP + 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.7.1.149 | pan-phosphatidylinositol 5-phosphate 4-kinase | - |
Homo sapiens |
2.7.1.149 | pan-PI5P4K | - |
Homo sapiens |
2.7.1.149 | PI5P4Kalpha | isoform | Homo sapiens |
2.7.1.149 | PI5P4Kbeta | isoform | Homo sapiens |
EC Number | IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|---|
2.7.1.149 | 0.00013 | - |
isoform PI5P4Kalpha, at pH 7.4 and 25°C | Homo sapiens | (Z)-N-(4-(5-((2,4-dioxothiazolidin-5-ylidene)methyl)pyridin-3-yl)phenyl)methanesulfonamide | |
2.7.1.149 | 0.00027 | - |
isoform PI5P4Kalpha, at pH 7.4 and 25°C | Homo sapiens | (Z)-N-(4-(5-((2-imino-4-oxothiazolidin-5-ylidene)methyl)pyridin-3-yl)phenyl)methanesulfonamide | |
2.7.1.149 | 0.00066 | - |
isoform PI5P4Kalpha, at pH 7.4 and 25°C | Homo sapiens | (Z)-N-(4-(2-amino-5-((2-imino-4-oxothiazolidin-5-ylidene)-methyl)pyridin-3-yl)phenyl)methanesulfonamide | |
2.7.1.149 | 0.0014 | - |
isoform PI5P4Kalpha, at pH 7.4 and 25°C | Homo sapiens | (Z)-4-(5-((2-imino-4-oxothiazolidin-5-ylidene)methyl)pyridin-3-yl)-N-methylbenzenesulfonamide | |
2.7.1.149 | 0.0017 | - |
isoform PI5P4Kbeta, at pH 7.4 and 25°C | Homo sapiens | (Z)-N-(4-(5-((2-imino-4-oxothiazolidin-5-ylidene)methyl)pyridin-3-yl)phenyl)methanesulfonamide | |
2.7.1.149 | 0.0018 | - |
isoform PI5P4Kalpha, at pH 7.4 and 25°C | Homo sapiens | (Z)-1-(4-(5-((2-imino-4-oxothiazolidin-5-ylidene)methyl)pyridin-3-yl)phenyl)-3-methylurea | |
2.7.1.149 | 0.0019 | - |
isoform PI5P4Kbeta, at pH 7.4 and 25°C | Homo sapiens | (Z)-N-(4-(5-((2,4-dioxothiazolidin-5-ylidene)methyl)pyridin-3-yl)phenyl)methanesulfonamide | |
2.7.1.149 | 0.002 | - |
isoform PI5P4Kalpha, at pH 7.4 and 25°C | Homo sapiens | N-(4-(5-(1H-indol-4-yl)pyridin-3-yl)phenyl)methanesulfonamide | |
2.7.1.149 | 0.0021 | - |
isoform PI5P4Kalpha, at pH 7.4 and 25°C | Homo sapiens | N-(5-(5-(1H-indol-4-yl)pyridin-3-yl)phenyl)methanesulfonamide | |
2.7.1.149 | 0.0027 | - |
isoform PI5P4Kbeta, at pH 7.4 and 25°C | Homo sapiens | (Z)-N-(4-(2-amino-5-((2-imino-4-oxothiazolidin-5-ylidene)-methyl)pyridin-3-yl)phenyl)methanesulfonamide | |
2.7.1.149 | 0.0032 | - |
isoform PI5P4Kalpha, at pH 7.4 and 25°C | Homo sapiens | N-(6-(5-(1H-indol-4-yl)pyridin-3-yl)phenyl)methanesulfonamide | |
2.7.1.149 | 0.0037 | - |
isoform PI5P4Kalpha, at pH 7.4 and 25°C | Homo sapiens | N-(4-(5-(4-(3-methylureido)phenyl)pyridin-3-yl)phenyl)methanesulfonamide | |
2.7.1.149 | 0.0039 | - |
isoform PI5P4Kalpha, at pH 7.4 and 25°C | Homo sapiens | (Z)-2-imino-5-((5-(4-methoxynaphthalen-1-yl)pyridin-3-yl)methylene)thiazolidin-4-one | |
2.7.1.149 | 0.004 | - |
isoform PI5P4Kalpha, at pH 7.4 and 25°C | Homo sapiens | (Z)-N-(4-(6-amino-5-((2-imino-4-oxothiazolidin-5-ylidene)methyl)pyridin-3-yl)phenyl)methanesulfonamide | |
2.7.1.149 | 0.0043 | - |
isoform PI5P4Kbeta, at pH 7.4 and 25°C | Homo sapiens | (Z)-4-(5-((2-imino-4-oxothiazolidin-5-ylidene)methyl)pyridin-3-yl)-N-methylbenzenesulfonamide | |
2.7.1.149 | 0.0053 | - |
isoform PI5P4Kalpha, at pH 7.4 and 25°C | Homo sapiens | N-(3-(5-(4-(methylsulfonamido)phenyl)pyridin-3-yl)phenyl)acetamide | |
2.7.1.149 | 0.0061 | - |
isoform PI5P4Kalpha, at pH 7.4 and 25°C | Homo sapiens | (E)-N-(4-(5-((2,5-dioxopyrrolidin-3-ylidene)methyl)pyridin-3-yl)phenyl)methanesulfonamide | |
2.7.1.149 | 0.0086 | - |
isoform PI5P4Kbeta, at pH 7.4 and 25°C | Homo sapiens | (Z)-1-(4-(5-((2-imino-4-oxothiazolidin-5-ylidene)methyl)pyridin-3-yl)phenyl)-3-methylurea | |
2.7.1.149 | 0.0088 | - |
isoform PI5P4Kalpha, at pH 7.4 and 25°C | Homo sapiens | (Z)-5-((5-(4-(dimethylamino)phenyl)pyridin-3-yl)methylene)-2-iminothiazolidin-4-one | |
2.7.1.149 | 0.0089 | - |
isoform PI5P4Kalpha, at pH 7.4 and 25°C | Homo sapiens | N-(4-(5-(2-oxoindolin-4yl)pyridin-3-yl)phenyl)methanesulfonamide | |
2.7.1.149 | 0.009 | - |
isoform PI5P4Kalpha, at pH 7.4 and 25°C | Homo sapiens | N-(3-((5-(4-(Mmthylsulfonamido)phenyl)pyridin-3-yl)oxy)phenyl)acetamide | |
2.7.1.149 | 0.0094 | - |
isoform PI5P4Kbeta, at pH 7.4 and 25°C | Homo sapiens | N-(4-(5-(1H-indol-4-yl)pyridin-3-yl)phenyl)methanesulfonamide | |
2.7.1.149 | 0.011 | - |
isoform PI5P4Kalpha, at pH 7.4 and 25°C | Homo sapiens | (Z)-2-imino-5-((5-(4-(trifluoromethoxy)phenyl)pyridin-3-yl)methylene)thiazolidin-4-one | |
2.7.1.149 | 0.011 | - |
isoform PI5P4Kalpha, at pH 7.4 and 25°C | Homo sapiens | (Z)-N-(3-(5-((2-imino-4-oxothiazolidin-5-ylidene)methyl)pyridin-3-yl)phenyl)acetamide | |
2.7.1.149 | 0.011 | - |
isoform PI5P4Kalpha, at pH 7.4 and 25°C | Homo sapiens | (Z)-N-(4-(5-((2-imino-4-oxothiazolidin-5-ylidene)methyl)pyridin-3-yl)phenyl)acetamide | |
2.7.1.149 | 0.014 | - |
isoform PI5P4Kalpha, at pH 7.4 and 25°C | Homo sapiens | N-(3-((5-(4-(methylsulfonamido)phenyl)pyridin-3-yl)amino)phenyl)acetamide | |
2.7.1.149 | 0.015 | - |
isoform PI5P4Kbeta, at pH 7.4 and 25°C | Homo sapiens | N-(4-(5-(2-oxoindolin-4yl)pyridin-3-yl)phenyl)methanesulfonamide | |
2.7.1.149 | 0.021 | - |
isoform PI5P4Kalpha, at pH 7.4 and 25°C | Homo sapiens | (Z)-N-(4-(5-((2,4-dioxo-oxazolidin-5-ylidene)methyl)pyridin-3-yl)phenyl)methanesulfonamide | |
2.7.1.149 | 0.022 | - |
isoform PI5P4Kbeta, at pH 7.4 and 25°C | Homo sapiens | N-(5-(5-(1H-indol-4-yl)pyridin-3-yl)phenyl)methanesulfonamide | |
2.7.1.149 | 0.025 | - |
isoform PI5P4Kbeta, at pH 7.4 and 25°C | Homo sapiens | (Z)-N-(4-(6-amino-5-((2-imino-4-oxothiazolidin-5-ylidene)methyl)pyridin-3-yl)phenyl)methanesulfonamide | |
2.7.1.149 | 0.025 | - |
isoform PI5P4Kbeta, at pH 7.4 and 25°C | Homo sapiens | N-(3-((5-(4-(Mmthylsulfonamido)phenyl)pyridin-3-yl)oxy)phenyl)acetamide | |
2.7.1.149 | 0.026 | - |
isoform PI5P4Kbeta, at pH 7.4 and 25°C | Homo sapiens | (Z)-2-imino-5-((5-(4-(trifluoromethyl)phenyl)pyridin-3-yl)methylene)thiazolidin-4-one | |
2.7.1.149 | 0.027 | - |
isoform PI5P4Kbeta, at pH 7.4 and 25°C | Homo sapiens | (E)-N-(4-(5-((2,5-dioxopyrrolidin-3-ylidene)methyl)pyridin-3-yl)phenyl)methanesulfonamide | |
2.7.1.149 | 0.028 | - |
isoform PI5P4Kbeta, at pH 7.4 and 25°C | Homo sapiens | (Z)-5-((5-(4-fluorophenyl)pyridin-3-yl)methylene)-2-iminothiazolidin-4-one | |
2.7.1.149 | 0.029 | - |
isoform PI5P4Kbeta, at pH 7.4 and 25°C | Homo sapiens | N-(6-(5-(1H-indol-4-yl)pyridin-3-yl)phenyl)methanesulfonamide | |
2.7.1.149 | 0.035 | - |
isoform PI5P4Kalpha, at pH 7.4 and 25°C | Homo sapiens | (Z)-2-imino-5-((5-(4-(methylsulfonyl)phenyl)pyridin-3-yl)methylene)thiazolidin-4-one | |
2.7.1.149 | 0.036 | - |
isoform PI5P4Kbeta, at pH 7.4 and 25°C | Homo sapiens | N-(3-(5-(4-(methylsulfonamido)phenyl)pyridin-3-yl)phenyl)acetamide | |
2.7.1.149 | 0.043 | - |
isoform PI5P4Kbeta, at pH 7.4 and 25°C | Homo sapiens | N-(4-(5-(4-(3-methylureido)phenyl)pyridin-3-yl)phenyl)methanesulfonamide | |
2.7.1.149 | 0.045 | - |
isoform PI5P4Kbeta, at pH 7.4 and 25°C | Homo sapiens | N-(3-((5-(4-(methylsulfonamido)phenyl)pyridin-3-yl)amino)phenyl)acetamide | |
2.7.1.149 | 0.05 | - |
IC50 above 0.05 mM, isoform PI5P4Kalpha, at pH 7.4 and 25°C | Homo sapiens | (Z)-2-imino-5-((5-(4-(trifluoromethyl)phenyl)pyridin-3-yl)methylene)thiazolidin-4-one | |
2.7.1.149 | 0.05 | - |
IC50 above 0.05 mM, isoform PI5P4Kalpha, at pH 7.4 and 25°C | Homo sapiens | (Z)-5-((5-(4-fluorophenyl)pyridin-3-yl)methylene)-2-iminothiazolidin-4-one | |
2.7.1.149 | 0.05 | - |
IC50 above 0.05 mM, isoform PI5P4Kbeta, at pH 7.4 and 25°C | Homo sapiens | (Z)-2-imino-5-((5-(4-(methylsulfonyl)phenyl)pyridin-3-yl)methylene)thiazolidin-4-one | |
2.7.1.149 | 0.05 | - |
IC50 above 0.05 mM, isoform PI5P4Kbeta, at pH 7.4 and 25°C | Homo sapiens | (Z)-2-imino-5-((5-(4-(trifluoromethoxy)phenyl)pyridin-3-yl)methylene)thiazolidin-4-one | |
2.7.1.149 | 0.05 | - |
IC50 above 0.05 mM, isoform PI5P4Kbeta, at pH 7.4 and 25°C | Homo sapiens | (Z)-2-imino-5-((5-(4-methoxynaphthalen-1-yl)pyridin-3-yl)methylene)thiazolidin-4-one | |
2.7.1.149 | 0.05 | - |
IC50 above 0.05 mM, isoform PI5P4Kbeta, at pH 7.4 and 25°C | Homo sapiens | (Z)-5-((5-(4-(dimethylamino)phenyl)pyridin-3-yl)methylene)-2-iminothiazolidin-4-one | |
2.7.1.149 | 0.05 | - |
IC50 above 0.05 mM, isoform PI5P4Kbeta, at pH 7.4 and 25°C | Homo sapiens | (Z)-N-(3-(5-((2-imino-4-oxothiazolidin-5-ylidene)methyl)pyridin-3-yl)phenyl)acetamide | |
2.7.1.149 | 0.05 | - |
IC50 above 0.05 mM, isoform PI5P4Kbeta, at pH 7.4 and 25°C | Homo sapiens | (Z)-N-(4-(5-((2,4-dioxo-oxazolidin-5-ylidene)methyl)pyridin-3-yl)phenyl)methanesulfonamide | |
2.7.1.149 | 0.05 | - |
IC50 above 0.05 mM, isoform PI5P4Kbeta, at pH 7.4 and 25°C | Homo sapiens | (Z)-N-(4-(5-((2-imino-4-oxothiazolidin-5-ylidene)methyl)pyridin-3-yl)phenyl)acetamide |